These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3312115)

  • 1. Radiobiologic implications of the microscopic distribution of energy from radionuclides.
    Adelstein SJ; Kassis AI
    Int J Rad Appl Instrum B; 1987; 14(3):165-9. PubMed ID: 3312115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy.
    Bloomer WD; Adelstein SJ
    Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-energy electron emitters for targeted radiotherapy of small tumours.
    Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
    Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
    Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
    Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6.
    Humm JL; Howell RW; Rao DV
    Med Phys; 1994 Dec; 21(12):1901-15. PubMed ID: 7700197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides.
    Goddu SM; Rao DV; Howell RW
    J Nucl Med; 1994 Mar; 35(3):521-30. PubMed ID: 8113908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide-antibody conjugates for single-cell cytotoxicity.
    Mattes MJ
    Cancer; 2002 Feb; 94(4 Suppl):1215-23. PubMed ID: 11877748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
    Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Radiometals Beyond
    Müller C; van der Meulen NP; Benešová M; Schibli R
    J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric aspects of radiolabeled antibodies for tumor therapy.
    Humm JL
    J Nucl Med; 1986 Sep; 27(9):1490-7. PubMed ID: 3528417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
    Karagiannis TC
    Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of nuclear medicine to the therapy of malignant tumors.
    Feinendegen LE
    J Cancer Res Clin Oncol; 1993; 119(6):320-2. PubMed ID: 8449968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects.
    Kampf G
    Radiobiol Radiother (Berl); 1990; 31(3):215-29. PubMed ID: 2201055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications.
    Bodei L; Kassis AI; Adelstein SJ; Mariani G
    Cancer Biother Radiopharm; 2003 Dec; 18(6):861-77. PubMed ID: 14969599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of targeted alpha therapy.
    Kim YS; Brechbiel MW
    Tumour Biol; 2012 Jun; 33(3):573-90. PubMed ID: 22143940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetically enhanced protection of bone marrow from beta particles emitted by bone-seeking radionuclides: theory of application.
    Raylman RR; Wahl RL
    Med Phys; 1995 Aug; 22(8):1285-92. PubMed ID: 7476715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microscopic features of dose from radionuclides, particularly emitters of alpha-particles and Auger electrons.
    Goodhead DT
    Int J Radiat Biol; 1991 Sep; 60(3):550-3. PubMed ID: 1679096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.